DMAC
Diamedica·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-28
Latest data update time: Updated on 2026-03-28
5.63 / 10Overall Score
NeturalInvestment Rating
5.63 / 10Overall Score
NeturalInvestment Rating
Is DMAC a Buy, Sell, or Hold?
- Based on a composite score of 5.63/10, we rate DMAC as a Netural. Our analysis breaks down into 4.94/10 for Fundamentals, 4.35/10 for Technicals, and 6.62/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of DMAC?
Is DMAC undervalued or overvalued?
What is the analyst consensus for DMAC?
Is DMAC a Buy, Sell, or Hold?
- Based on a composite score of 5.63/10, we rate DMAC as a Netural. Our analysis breaks down into 4.94/10 for Fundamentals, 4.35/10 for Technicals, and 6.62/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is DMAC undervalued or overvalued?
Technical Analysis of DMAC?
What is the analyst consensus for DMAC?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
